Liji Chen

Liji Chen

Auto-generated profile, based on publicly available information

Liji Chen

Dongguan Key Laboratory of Stem Cell and Regenerative Tissue Engineering, The First Dongguan Affiliated Hospital, School of Basic Medical Sciences Guangdong Medical University Dongguan China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 September 2022 in CARTILAGE
Verified
Journal Article
Open access
YLYinru Liang
Yinru Liang
JLJuan Li
Juan Li
YWYuhui Wang
Yuhui Wang
JHJunchu He
Junchu He
LCLiji Chen
Liji Chen
HWHong Wu
Hong Wu
Objective: This paper reviews the research of platelet-rich plasma (PRP) in articular cartilage injury repair, to assess the mechanism, utilization, and efficacy of PRP in the treatment of articular cartilage injury, hoping to provide a theoretical basis for the clinical application of PRP in the future. Materials and Methods: A comprehensive database search on PRP applications in cartilage repair was performed. Among them, the retrieval time range of PRP in clinical trials of repairing knee cartilage injury was from January 1, 2021 to January 1, 2022. Non-clinical trials and studies unrelated to cartilage injury were excluded. Result: PRP can affect inflammation, angiogenesis, cartilage protection, and cellular proliferation and differentiation after articular cartilage injury through different pathways. In all, 13 clinical trials were included in the analysis. Conclusion: PRP is an emergent therapeutic approach in tissue engineering. Most studies reported that PRP has a positive effect on cartilage injury, improving the joint function, meanwhile there is a lack of standardized standards. The technology of PRP in the repair and treatment of articular cartilage injury is worthy of further research.

7 November 2023 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
HWHongfu Wu
Hongfu Wu
TWTao Wang
Tao Wang
YLYinru Liang
Yinru Liang
LCLiji Chen
Liji Chen
ZLZiyi Li
Ziyi Li

22 June 2021 in Journal of Orthopaedic Surgery and Research
Verified
Journal Article
Open access
PDF file
Chang ZhouChang Zhou
Chang Zhou
THTianda He
Tianda He
LCLiji Chen
Liji Chen
Background: Osteoarthritis (OA) is one kind of degenerative joint disease that happens in articular cartilage and other joint tissues. Long non-coding RNAs (lncRNAs) have been reported to serve as pivotal regulators in many diseases, including OA. However, the role and relevant regulatory mechanisms of CASC19 in OA remain unknown. Methods: The expression levels of CASC19, miR-152-3p, and DDX6 were identified by reverse-transcription polymerase chain reaction (RT-qPCR). Cell viability and apoptosis were determined by Cell Counting Kit-8 (CCK-8) and flow cytometry assays, respectively. The relationship between miR-152-3p and CASC19 or DDX6 was predicted by bioinformatics tools and verified by the dual-luciferase reporter assay. Results: CASC19 was verified to exhibit higher expression in OA tissues and cells. Moreover, inhibition of CASC19 weakened proinflammatory cytokine (IL-6, IL-8, and TNF-α) production and cell apoptosis but facilitated cell viability. Experiments of the ceRNA mechanism elucidated that miR-152-3p was a sponge for CASC19, and miR-152-3p targeted DDX6, suggesting that CASC19 sponged miR-152-3p to release DDX6. Finally, results from rescue assays proved that the impacts of CASC19 silencing on chondrocytes apoptosis and proinflammatory cytokine production could be reversed by DDX6 overexpression. Conclusions: It was concluded that lncRNA CASC19 accelerated chondrocytes apoptosis and proinflammatory cytokine production to exacerbate osteoarthritis development through regulating the miR-152-3p/DDX6 axis. These findings may offer an effective biological target for OA treatment.

3 January 2025 in CNS Neuroscience & Therapeutics
Verified
Journal Article
Open access
JZJie Zhao
Jie Zhao
KCKangzhen Chen
Kangzhen Chen
TWTao Wang
Tao Wang
XQXianxiu Qiu
Xianxiu Qiu
XZXiaomin Zhang
Xiaomin Zhang
HWHong Wu
Hong Wu
Aims: Neuron death is caused primarily by apoptosis after spinal cord injury (SCI). Autophagy, as a cellular response, can maintain cellular homeostasis to reduce apoptosis. We aimed to investigate the effect and the mechanism of vimentin knockdown on autophagy and neural recovery after SCI.Methods: The SD rats with T10 complete transection as SCI model were used. The vimentin RNAi adenovirus was constructed and transplanted into T10 rats with total transection injury of the spinal cord, and the recovery of neurological and motor functions after SCI was evaluated by BBB score, footprint analysis, electrophysiological tests, and immunofluorescence staining. Protein and gene expression were assessed by Western blotting, CO‐IP, q‐PCR, and immunofluorescence. In addition, neuron‐like PC12 cells were infected with adenovirus to further elucidate the effect of vimentin on autophagy and the molecular mechanism of neuronal apoptosis after SCI.Results: Inhibition of SCI induced‐vimentin upregulation improved motor function, enhanced the recovery of autophagy flux, and reduced neuronal apoptosis. Notably, this may be related to the formation of vimentin‐14‐3‐3‐Beclin1 complex and PI3K class III complex.Conclusion: Our results suggest that inhibition of vimentin expression may enhance autophagy and anti‐apoptosis in neurons after SCI by affecting the formation of the vimentin‐14‐3‐3‐Beclin1 complex, thereby promoting neuronal recovery.